Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Selling goods	114.94M				227.45M	197.83M	66.30M	-
Services	78.48M				111.01M	35.38M	7.64M	3.15M
Molecular Detection Products - Nucleic Acid Preservation Reagent	-				-	-	-	12.43M
Molecular Detection Products - Nucleic Acid Extraction and Purification Reagents	-				-	-	-	12.60M
Other	-				-	-	-	1.05M
Molecular Detection Products - Raw Enzymes and Detection Reagents	-				-	-	-	26.59M
Total	193.41M				338.46M	233.21M	73.94M	55.83M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
China	179.15M				290.69M	206.68M	72.82M	55.69M
Foreign	14.27M				47.78M	26.53M	1.12M	136.30K
Total	193.41M				338.46M	233.21M	73.94M	55.83M

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error